Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
Combining the actual results with the estimates for the still-to-report companies, total earnings for the healthcare sector are expected to decline 9% on revenue growth of 4.3%.
This healthcare ETF hits a new 52-week high. Are more gains in store for this ETF?
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 138 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
Here are the top-performing sector ETFs of 2022. These include energy, healthcare, materials, utilities and consumer staples.
Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from the...
We all know that Wall Street is shattered this year. Still, two sectors -- Biotech and Aerospace -- have recently hit a 52-week high.
The Q3 earnings picture for the healthcare sector seems solid, with results from companies that have reported so far up 2.1% on 5.8% revenue growth.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 129 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.
First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 135 exchange-traded fund(s) (each a “Fund,” collectively, the “Funds”) advised by FTA.